Adaptimmune Therapeutics plc (ADAP) |
|
1.63 0.17 (11.64%)
|
08-16 16:00 |
|
Open: |
1.45 |
Pre. Close: |
1.46 |
|
High:
|
1.78 |
Low:
|
1.44 |
|
Volume:
|
322,424 |
Market Cap:
|
171M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.783 - 1.793 |
1.793 - 1.802 |
|
Low:
|
1.418 - 1.429 |
1.429 - 1.439 |
|
Close:
|
1.612 - 1.63 |
1.63 - 1.646 |
|
Technical analysis |
as of: 2019-08-16 4:45:40 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 3.41  One year: 4.49 |
| Support: |
Support1: 1.44 Support2: 1.20 |
| Resistance: |
Resistance1: 2.92 Resistance2: 3.84 |
| Pivot: |
2.23 |
| Moving Average: |
MA(5): 1.61 MA(20): 2.51
MA(100): 3.69 MA(250): 5.69 |
| MACD: |
MACD(12,26): -0.51 Signal(9): -0.43 |
| Stochastic oscillator: |
%K(14,3): 3.42 %D(3): 3.47 |
| RSI: |
RSI(14): 26.65 |
| 52-week: |
High: 14.54 Low: 1.44 Change(%): -80.8 |
| Average Vol(K): |
3-Month: 29007 10-Days: 44277 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.ADAP has closed above bottom band by 25.8%. Bollinger Bands are 117% wider than normal. The large width of the bands suggest high volatility as compared to ADAP's normal range. The bands have been in this wide range for 9 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Fri, 16 Aug 2019 17:13:04 Z
What's in Store for Aytu BioScience's (AYTU) Q4 Earnings?
Fri, 02 Aug 2019 03:56:49 Z
Adaptimmune Therapeutics (ADAP) Q2 2019 Earnings Call Transcript
Tue, 09 Jul 2019 17:07:17 Z
Athenex (ATNX) in Focus: Stock Moves 6.5% Higher
Tue, 09 Jul 2019 15:17:46 Z
Adaptimmune Therapeutics PLC (ADAP) Upgraded to Strong Buy: Here's Why
Mon, 28 Jan 2019 16:51:24 Z
Adaptimmune Therapeutics PLC (ADAP) Upgraded to Buy: Here's What You Should Know
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
